On 31 January 2017 the WHO Secretariat published the “Draft decision resulting from informal consultations” on the Overall programme review of the global strategy and plan of action on public health, innovation and intellectual property (EB140/CONF./7 Rev.1). This can be found here: http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_CONF7Rev1-en.pdf
The chapeau to this decision notes:
The Executive Board decided to approve the terms of reference of the overall programme review of the global strategy and plan of action on public health, innovation and intellectual property, set out in the Annex to this decision, and also to request the Secretariat to develop an indication of funding requirements and possible sources of the implementation costs of the recommendations of the programme review, and present these to the Seventy-first World Health Assembly in 2018 through the Executive Board at its 142nd session.
The text of the decision is contained below. On Monday, 31 January 2017, the 140th session of the Executive Board (EB) adopted the decision during its morning session.
ANNEX
TERMS OF REFERENCE OF THE OVERALL PROGRAMME REVIEW1. As directed in resolution WHA68.18 (2015), the overall programme review, as distinct from the evaluation, will be a more policy-oriented, forward-looking exercise. The expert review panel’s conclusions should identify areas of convergence, in line with the 10 principles of the global strategy and plan of action on public health, innovation and intellectual property (contained in the annex to resolution WHA61.21 (2008)). Guided by the report of the comprehensive evaluation and, where appropriate, taking into account other evidence and involving relevant stakeholders, including public sector entities and all categories of non-State actors in line with FENSA involved in biomedical research and development, the programme review will:
(a) assess the continued relevance of the aim and objectives and the eight elements of the global strategy and plan of action;
(b) consider the evaluation of the implementation of the global strategy and plan of action so far and its key barriers;
(c) review achievements, good practices, success factors, opportunities, gaps, weaknesses, unsuccessful efforts, remaining challenges, and value for money;
(d) invite, over the course of the evaluation, appropriate input and comment from WIPO, WTO, and UNCTAD and other relevant intergovernmental organizations;
(e) recommend a way forward, including details of what elements or actions should be added, enhanced or concluded in the next stage of implementation of the global strategy and plan of action on public health, innovation and intellectual property, until 2022;
(f) submit a final report to the Health Assembly, including the assessment of the global strategy and plan of action and recommendations on the way forward.
2. The final report of the overall programme review of the global strategy and plan of action on public health, innovation and intellectual property, focusing on its achievements, remaining challenges and recommendations on the way forward will be presented to the Seventy-first World Health Assembly in 2018 through the Executive Board at its 142nd session.